|
Drug Topics
Hospital
Pharmacists' Report
DrugTopics.com
January 26, 2012 |
HHS News
Getting new Alzheimer’s drugs to market quickly was 1 of the initiatives discussed during the mid-January meeting of the Advisory Council on Alzheimer’s Research, Care, and Services in Washington, D.C. » More |
CLINICAL NEWS
Approximately 1 in 100 patients undergoing total or partial knee replacement surgery and 1 in 200 patients undergoing total or partial hip replacement surgery will experience a venous thromboembolism event, including deep vein thrombosis and pulmonary embolism, before being discharged from the hospital, according to a study reported January 18 in the Journal of the American Medical Association. » More |
|
Silent embolic cerebral infarctions occur in about 1 in 6 patients after undergoing coronary angiography, and the risk is related to the degree of platelet inhibition with aspirin and clopidogrel, a Korean study shows. » More |
|
The Endocrine Society recently released new clinical practice guidelines recommending that all patients have their blood-glucose levels tested upon admission to the hospital, even if they haven’t had a prior diagnosis of diabetes. » More |
CONTINUING EDUCATION
Also known as syndrome X or metabolic syndrome, this condition can lead to diabetes, hypertension, and cardiovascular disease. For patients, pharmacists are an ideal source of information and support. Earn up to 2 CPE credits. » Click here to login and take the exams. |
FDA ACTIONS
FDA approved ingenol mebutate (Picato, LEO Pharma) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis (AK). It is the first topical AK therapy that can be used for as few as 2 or 3 consecutive days. » More |
MEDICATION SAFETY
Welcome to the latest public health emergency: Shortages of anti-infective agents. These shortages can adversely affect clinical care and patient outcomes, according to a new study. » More |
|
Seattle Genetics Inc. said it found a second instance of a patient on its cancer drug brentuximab vedotin (Adcetris) developing progressive multifocal leukoencephalopathy, prompting the company and regulators to include a boxed warning on the drug's label. » More |
|
Aspirin prophylaxis in people without prior cardiovascular disease does not appear to reduce cardiovascular death or cancer mortality, however it was associated with reductions in nonfatal myocardial infarction, according to the results of a meta-analysis published online January 9 in the Archives of Internal Medicine. » More |
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
